Clinical Trial Update: Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating recombinant human thrombopoietin for increasing platelet levels in ICU patients with pneumonia and thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Thrombocytopenia

Drugs mentioned

• recombinant human thrombopoietin (recombinant human thrombopoietin)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Pneumonia, Thrombocytopenia | Phase 4 | Status: UNKNOWN